Logo image
Genome-wide association study of major anxiety disorders in 122,341 European-ancestry cases identifies 58 loci and highlights GABAergic signaling
Journal article   Open access   Peer reviewed

Genome-wide association study of major anxiety disorders in 122,341 European-ancestry cases identifies 58 loci and highlights GABAergic signaling

Nora I Strom, Brad Verhulst, Silviu-Alin Bacanu, Rosa Cheesman, Kirstin L Purves, Hüseyin Gedik, Brittany L Mitchell, Alex S Kwong, Annika B Faucon, Kritika Singh, …
Nature Genetics, Vol.58, pp.275-288
03/02/2026
Handle:
https://hdl.handle.net/10523/50003

Abstract

Genetic association study GWAS anxiety disorders
The major anxiety disorders (ANX; including generalized anxiety disorder, panic disorder and phobias) are highly prevalent, often onset early and cause substantial global disability. Although distinct in their clinical presentations, they probably represent differential expressions of a dysregulated threat–response system. Here, we present a genome-wide association meta-analysis comprising 122,341 European ancestry ANX cases and 729,881 controls. We identified 58 independent genome-wide significant risk variants and 66 genes with robust biological support. In an independent sample of 1,175,012 self-report ANX cases and 1,956,379 controls, 51 out of the 58 associations replicated. As predicted by twin studies, we found substantial genetic correlation between ANX and depression, neuroticism and other internalizing phenotypes. Follow-up analyses demonstrated enrichment in all major brain regions and highlighted GABAergic signaling as one potential mechanism implicated in ANX genetic risk. These results advance our understanding of the genetic architecture of ANX and prioritize genes for functional follow-up studies.
pdf
s41588-025-02485-83.20 MBDownloadView
Published (Version of record)CC BY V4.0 Open Access
url
https://doi.org/10.1038/s41588-025-02485-8View
Published (Version of record)CC BY V4.0 Open

Metrics

1 Record Views

Details

Logo image